Company intelligence / Profile preview

Aiberry

Bellevue, Washington, United Statesaiberry.com ↗

Ownership: Private
Development stage: Commercial

Overview

Aiberry has completed a clinical validation study with The University of Texas at Austin demonstrating its AI model for depression risk assessment to be clinically equivalent to gold-standard questionnaires and unbiased across gender, age, or race. The platform provides nuanced insights into mood and symptomatology beyond traditional forms. Ongoing multi-site studies are further validating the technology.

Therapeutic areas: Psychiatry
Modalities: Non-pharmacological therapyDevice (AI-powered digital assessment tool)
Industry: Digital Health Medical Devices

Partnerships

Collaborations with academic institutions including Georgetown University Medical Center and the University of Arizona for clinical validation studies.

Beyond the preview

Go deeper on Aiberry.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aiberry.

Explore the full profile